ArticleJCO clinical cancer informatics2025

Using Early Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Patients With Chronic Myeloid Leukemia Who Are in Remission.

J Felipe Montano-Campos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.